G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $172,800 | +73.5% | 120,000 | +200.0% | 0.15% | +96.0% |
Q2 2023 | $99,600 | +92984.1% | 40,000 | 0.0% | 0.08% | -10.7% |
Q1 2023 | $107 | -50.7% | 40,000 | 0.0% | 0.08% | -45.1% |
Q4 2022 | $217 | -100.0% | 40,000 | 0.0% | 0.15% | -56.5% |
Q3 2022 | $500,000 | +152.5% | 40,000 | 0.0% | 0.35% | +144.4% |
Q2 2022 | $198,000 | -34.9% | 40,000 | 0.0% | 0.14% | -34.2% |
Q1 2022 | $304,000 | -25.5% | 40,000 | 0.0% | 0.22% | -16.7% |
Q4 2021 | $408,000 | -24.0% | 40,000 | 0.0% | 0.26% | -27.9% |
Q3 2021 | $537,000 | -38.8% | 40,000 | 0.0% | 0.36% | -30.5% |
Q2 2021 | $878,000 | -8.7% | 40,000 | 0.0% | 0.52% | -8.1% |
Q1 2021 | $962,000 | +33.6% | 40,000 | 0.0% | 0.57% | +37.6% |
Q4 2020 | $720,000 | -22.1% | 40,000 | -50.0% | 0.42% | +34.3% |
Q3 2020 | $924,000 | -4.7% | 80,000 | +100.0% | 0.31% | -47.3% |
Q2 2020 | $970,000 | +120.0% | 40,000 | 0.0% | 0.59% | +49.9% |
Q1 2020 | $441,000 | -58.3% | 40,000 | 0.0% | 0.39% | -49.1% |
Q4 2019 | $1,057,000 | +16.0% | 40,000 | 0.0% | 0.77% | +26.5% |
Q3 2019 | $911,000 | -25.7% | 40,000 | 0.0% | 0.61% | -18.6% |
Q2 2019 | $1,226,000 | +392.4% | 40,000 | +166.7% | 0.75% | +378.2% |
Q1 2019 | $249,000 | -13.2% | 15,000 | 0.0% | 0.16% | -42.4% |
Q4 2018 | $287,000 | -63.4% | 15,000 | 0.0% | 0.27% | -46.4% |
Q3 2018 | $784,000 | -18.0% | 15,000 | -31.8% | 0.51% | -22.2% |
Q2 2018 | $956,000 | +17.3% | 22,000 | 0.0% | 0.65% | +21.0% |
Q1 2018 | $815,000 | – | 22,000 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
RA Capital Management | 363,051 | $6,027,000 | 0.26% |
BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |